Home » Unicancer research » Unicancer R&D » Unicancer R&D publications

Unicancer R&D publications

Publications

2016

Analysing patients presenting an exceptional and unexpected response in oncology: recent initiatives [article in ...

Charles Ferté et al., ITO. 2016 Jun ; 2(3) :135-140.

2016

Equal access to innovative therapies and precision cancer care

Buzyn A et al., Nat Rev Clin Oncol. 2016 Jun;13(6):385-93

2016

Mutational profile of metastatic breast cancers: a retrospective analysis

Lefebvre C et al., PLoS Med. 2016 Dec 27;13(12)

2016

What specifications for a centre or network of excellence in clinical research ?

Diebolt V et al., Thérapie (2016) 71, 51-57

2016

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, ...

Piperno-Neumann S et al., Lancet Oncol. 2016 Aug;17(8):1070-80.

View all publications
Oral communications and posters

2018

Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: the ...

Vassal et al., ASCO

2018

Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant ...

Conroy et al., ASCO

2018

Résultats d’une large étude de phase III multicentrique française – association chimio-hyperthermie ...

Quenet et al., ASCO

2018

REGOBONE : essai de phase II en double aveugle contre placebo du Groupe Sarcomes Français (GSF-GETO) évaluant ...

Duffaud et al., ASCO

2018

PADA-1: essai de phase III évaluant la tolérance et l’efficacité du palbociclib (Pal) associé à une thérapie ...

Bidard et al., ASCO

See all presentations